These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23479983)

  • 21. Quality of life in opium-addicted patients with coronary artery disease as measured with WHOQOL-BREF.
    Najafi M; Sheikhvatan M; Montazeri A; Sheikhfathollahi M
    Int J Soc Psychiatry; 2009 May; 55(3):247-56. PubMed ID: 19383668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic syndrome does not impact long-term survival in patients with acute myocardial infarction after successful percutaneous coronary intervention with drug-eluting stents.
    Won KB; Kim BK; Chang HJ; Shin DH; Kim JS; Ko YG; Choi D; Ha JW; Hong MK; Jang Y
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):713-20. PubMed ID: 23934969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals.
    Voulgari C; Tentolouris N; Dilaveris P; Tousoulis D; Katsilambros N; Stefanadis C
    J Am Coll Cardiol; 2011 Sep; 58(13):1343-50. PubMed ID: 21920263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk Factors and Markers for Acute Myocardial Infarction With Angiographically Normal Coronary Arteries.
    Daniel M; Ekenbäck C; Agewall S; Brolin EB; Caidahl K; Cederlund K; Collste O; Eurenius L; Frick M; Younis-Hassan S; Henareh L; Jernberg T; Malmqvist K; Spaak J; Sörensson P; Hofman-Bang C; Tornvall P
    Am J Cardiol; 2015 Sep; 116(6):838-44. PubMed ID: 26251000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Quality of life of patients with old myocardial infarction on prolonged therapy with atenolol].
    Kaliuzhin VV; Tepliakov AT; Kaliuzhina EV; Solovtsev MA; Maleeva MA; Pushnikova EIu
    Klin Med (Mosk); 2006; 84(1):50-2. PubMed ID: 16512398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type-D personality: a predictor of quality of life and coronary heart disease.
    Saeed T; Niazi GS; Almas S
    East Mediterr Health J; 2011 Jan; 17(1):46-50. PubMed ID: 21735801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Timely estimation of risk factors of coronary heart disease as a basis of prevention of its complications].
    Matveeva SA
    Klin Med (Mosk); 2012; 90(11):19-23. PubMed ID: 23516847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Autonomic regulation and emotional status in patients with ischemic heart disease having pain syndrome of various severity].
    Ibatov AD; Syrkin AL; Veĭn AM; Syrkina EA; Baevskiĭ RM; Ibatova OV
    Klin Med (Mosk); 2003; 81(12):36-40. PubMed ID: 14971155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals: HUNT (Nord-Trøndelag Health Study), Norway.
    Mørkedal B; Vatten LJ; Romundstad PR; Laugsand LE; Janszky I
    J Am Coll Cardiol; 2014 Mar; 63(11):1071-8. PubMed ID: 24345592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of life and insulin resistance in patients with coronary heart disease.
    Agewall S; Henareh L
    Coron Artery Dis; 2008 Aug; 19(5):289-92. PubMed ID: 18607164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in Health Related Quality of Life 3 months after an acute coronary syndrome.
    Failde II; Soto MM
    BMC Public Health; 2006 Jan; 6():18. PubMed ID: 16441887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of metabolic syndrome in acute myocardial infarction at hospital.
    Islam MS; Bari MA; Paul GK; Islam MZ; Rahman MZ; Hoshneara M; Karim MA; Nabi MN; Pandit H
    Mymensingh Med J; 2013 Apr; 22(2):261-6. PubMed ID: 23715346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic syndrome and its components as predictors of all-cause mortality and coronary heart disease in type 2 diabetic patients.
    Protopsaltis I; Nikolopoulos G; Dimou E; Brestas P; Kokkoris S; Korantzopoulos P; Melidonis A
    Atherosclerosis; 2007 Nov; 195(1):189-94. PubMed ID: 17064711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left ventricular size and function in patients with noninsulin-dependent diabetes and postinfarction total or subtotal coronary occlusions.
    Dini FL; Volterrani C; Azzarelli A; Lanciani A; Lunardi M; Bernardi D; Micheli G
    Angiology; 1998 Dec; 49(12):967-73. PubMed ID: 9855371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between coronary heart disease and individual components of the metabolic syndrome according to glucose tolerance status.
    Gong X; Pan X; Chen X; Hong C; Hong J; Shen F
    J Int Med Res; 2012; 40(3):934-42. PubMed ID: 22906266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
    Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
    Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of lisinopril on cardiac remodeling in patients with cardiosclerosis after myocardial infarction and signs of chronic heart failure].
    Blagodar VN; Petriĭ VV; Makolkin VI
    Kardiologiia; 2003; 43(9):17-20. PubMed ID: 14682288
    [No Abstract]   [Full Text] [Related]  

  • 39. Relationship between metabolic syndrome (MS) and coronary heart disease (CHD) in an aged group.
    Chen Q; Liu Y; Yin Y; Huang W; Li G; Ke D
    Arch Gerontol Geriatr; 2008; 46(1):107-15. PubMed ID: 17482687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease.
    Paul-Labrador M; Polk D; Dwyer JH; Velasquez I; Nidich S; Rainforth M; Schneider R; Merz CN
    Arch Intern Med; 2006 Jun; 166(11):1218-24. PubMed ID: 16772250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.